Double Medical Technology Hits Day Low of CNY 45.19 Amid Price Pressure

Double Medical Technology, Inc. experienced a notable decline today, with the stock dropping by 3.55% on March 4, 2026. The stock reached an intraday low of CNY 45.19, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 5.81%, contrasting with a slight gain of 0.41% in the China Shanghai Composite index. In terms of longer-term performance, Double Medical has shown a year-to-date decline of 4.16%, while the broader market has gained 2.85%. However, the company has demonstrated resilience over the past year, achieving a return of 33.8%, significantly outperforming the China Shanghai Composite's 22.49% return. Financial metrics indicate that Double Medical has maintained a strong operational performance, with net sales for the first nine months growing by 41.82% to CNY 1,699.51 million. The company also reported its highest operating cash flow at CNY 428.8 million. Despite today's downturn, the stock remains a significant player in the pharmaceuticals and biotechnology sector, backed by a market capitalization of CNY 16,653 million.